Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |